Diskussionsleiter: C. F. H. Müller (Bonn), K. Ziegler (München)
| (P1538) | DNA-dependent protein kinase (DNA-PK) mediates Y box binding-protein-1 (YB-1) activation | |
| N. Schulien, S. Medunjanin, S. Weinert, A. Schmeißer, R. Braun-Dullaeus (Magdeburg) | ||
| (P1539) | DNA-PK controls NF-kappaB activity via IKKγ/NEMO | |
| S. Medunjanin, S. Weinert, A. Schmeißer, R. Braun-Dullaeus (Magdeburg) | ||
| (P1540) | The endothelial cell transcriptome and epigenome in experimental heart failure | |
| L. Deng, M. Barg, R. Gilsbach, T. Schnick, C. Bode, L. Hein, A. Lother (Freiburg im Breisgau) | ||
| (P1541) | Identification of proteomic changes and potential targets in neointima formation by high-resolution mass spectrometry in single femoral arteries | |
| M. Wierer, J. Werner, G. Cepele, M. Prestel, Z. Aherrahrou, J. Erdmann, M. Dichgans, H. Sager, V. Flockerzi, T. Keßler, M. Mann, H. Schunkert (Martinsried, München, Lübeck, Homburg) | ||
| (P1542) | Cardiac epitope mapping in the frame of myocardial infarction | |
| N. Hapke, C. Gaal, S. M. Heinrichs, G. Ramos, U. Hofmann, S. Frantz (Würzburg) | ||
| (P1543) | Targeting protease-activated receptor 1 (PAR1) with vorapaxar attenuates atherosclerosis in apolipoprotein E-deficient mice | |
| J. Friebel, B. H. Rauch, A. Böhm, E. Moritz, M. Witkowski, T. Tabaraie, A. Dörner, A. Haghikia, O. Galuszka, D. Steffens, M. Kasner, U. Landmesser, U. Rauch-Kröhnert (Berlin, Greifswald) | ||
| (P1544) | The polarity protein Scrib limits atherosclerosis development in mice | |
| C. Schürmann, F. Dienst, E. Vasconez, K. Pálfi, J. A. Oo, F. Hahner, S. Wang, S. Offermanns, M. S. Leisegang, C. Kruse, R. P. Brandes (Frankfurt am Main, Bad Nauheim) | ||
| (P1545) | Gene Expression Profiling of Endothelial Cells in Chronic Thromboembolic Pulmonary Hypertension | |
| M. Bochenek, K. Saar, M. Nazari Jahantigh, N. Hübner, A. Schober, T. Münzel, E. Mayer, S. Konstantinides, K. Schäfer (Mainz, Berlin, München, Bad Nauheim) |
